Skip to main content

Interventional Endoscopy

Center for Interventional Endoscopy

Clinical Trials

Showing 1-9 out of 21 results.
NCT03926130

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.

Icon for trial | I6T-MC-AMAM A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.

This study is currently enrolling.

The main reason for you to take part in this study is not to treat you for your condition but to help in answering the following research questions: How safe mirikizumab is and whether you might have any side effects when you t ...

NCT05046730

SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression: A Study to Evaluate Safety and Effectiveness of the GI Window’s Self-Forming Magnet (SFM) Anastomosis Device: A Historically Controlled Propensity Matched Study

Icon for trial | GIW 21-002 SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression: A Study to Evaluate Safety and Effectiveness of the GI Window’s Self-Forming Magnet (SFM) Anastomosis Device: A Historically  Controlled Propensity Matched Study

This study is currently enrolling.

You are being asked to participate in this research study because you will be undergoing an ileostomy reversal surgery (also referred to as “ileostomy closure”). A reversal of ileostomy is an operation to close your temporary i ...

NCT03466411

A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Subject with Moderately to Severely Active Crohn’s Disease

Icon for trial | CNTO1959CRD3001 A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Subject with Moderately to Severely Active Crohn’s Disease

This study is currently enrolling.

There are 3 separate studies being described in this form. All 3 studies have the same primary purposes, but there are some small differences between GALAXI 1 (which is a Phase 2 study) and GALAXI 2 & 3 (which are identical ...